during COVID-19 of clozapine treatment in patients with

[1]  David Taylor,et al.  COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine , 2021, Journal of psychiatry & neuroscience : JPN.

[2]  S. Bonaccorso,et al.  Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report , 2021, Brain, Behavior, & Immunity - Health.

[3]  D. Goff,et al.  Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. , 2021, JAMA psychiatry.

[4]  Zina M. Ibrahim,et al.  The side effect profile of Clozapine in real world data of three large mental health hospitals , 2020, PloS one.

[5]  Shufa Zheng,et al.  Associations between hematological parameters and disease severity in patients with SARS‐CoV‐2 infection , 2020, Journal of clinical laboratory analysis.

[6]  Paul J. Harrison,et al.  Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA , 2020, The Lancet Psychiatry.

[7]  P. Jha,et al.  Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[8]  N. Volkow,et al.  Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States , 2020, World psychiatry : official journal of the World Psychiatric Association.

[9]  Brahim Admou,et al.  Lymphopenia in critically ill COVID‐19 patients: A predictor factor of severity and mortality , 2020, International journal of laboratory hematology.

[10]  Y. Ahn,et al.  Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study , 2020, The Lancet Psychiatry.

[11]  David Taylor,et al.  Clozapine prescribing in COVID-19 positive medical inpatients: a case series , 2020, Therapeutic advances in psychopharmacology.

[12]  P. Falkai,et al.  Impact of smoking behavior on clozapine blood levels – a systematic review and meta‐analysis , 2020, Acta psychiatrica Scandinavica.

[13]  J. Krystal,et al.  Association of a Prior Psychiatric Diagnosis With Mortality Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Infection , 2020, JAMA network open.

[14]  J. MacCabe,et al.  Clozapine treatment and risk of COVID-19 infection: retrospective cohort study , 2020, The British Journal of Psychiatry.

[15]  S. Pathak,et al.  Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[16]  Nazar Zaki,et al.  Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[17]  G. Fricchione,et al.  Clozapine Toxicity in the Setting of COVID-19 , 2020, Psychosomatics.

[18]  T. Cranshaw,et al.  COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion , 2020, Schizophrenia bulletin.

[19]  S. Shergill,et al.  Management of clozapine treatment during the COVID-19 pandemic , 2020, Therapeutic advances in psychopharmacology.

[20]  H. Rogers,et al.  COVID‐19 and the clinical hematology laboratory , 2020, International journal of laboratory hematology.

[21]  Theodora Psaltopoulou,et al.  Hematological findings and complications of COVID‐19 , 2020, American journal of hematology.

[22]  W. Honer,et al.  Consensus statement on the use of clozapine during the COVID-19 pandemic , 2020, Journal of psychiatry & neuroscience : JPN.

[23]  Navdeep Singh,et al.  Isolated Chronic and Transient Neutropenia , 2019, Cureus.

[24]  I. Filipčić,et al.  Schizophrenia and Physical Comorbidity. , 2018, Psychiatria Danubina.

[25]  B. Curtis.  Non-chemotherapy drug-induced neutropenia: key points to manage the challenges. , 2017, Hematology. American Society of Hematology. Education Program.

[26]  B. Baune,et al.  Elevated clozapine levels associated with infection: A systematic review , 2017, Schizophrenia Research.

[27]  D. Siskind,et al.  Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis , 2016, British Journal of Psychiatry.

[28]  J. Palmblad,et al.  How we diagnose and treat neutropenia in adults , 2016, Expert review of hematology.

[29]  E. Andreakos,et al.  Neutrophils in viral infections: Current concepts and caveats , 2015, Journal of leukocyte biology.

[30]  Del D. Miller,et al.  Review and management of clozapine side effects. , 2000, The Journal of clinical psychiatry.